Walker Luke Nathaniel

CIK 00017014404 companiesPHILADELPHIA, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001701440

Recent Transactions

34 trades

Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2026-06-24+45,000→ 45,000 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2026-06-16+57,100→ 201,384 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-06-17+57,603→ 144,284 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2025-06-12+123,500→ 123,500 total
Purchase
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-01-31$1.76/sh+14,200→ 86,681 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2024-09-04+19,315→ 19,315 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-05-24+72,481→ 72,481 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-03-11−10,000→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−135,000→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-03-11−30,500→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-01-07+115,000→ 135,000 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-11-26+20,000→ 20,000 total
Award
Harpoon Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-24+100,000→ 100,000 total
Award
Harpoon Therapeutics, Inc.
Employee Stock Option (right to buy)
2022-10-03+305,000→ 305,000 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−1,250→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−20,834→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−35,100→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−50,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−12,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−2,500→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−5,834→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−7,800→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−130,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−1,250→ 0 total
Disposition from Tender
Cascadian Therapeutics, Inc.
Common Stock
2018-03-09−10,315→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−2,500→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−334→ 0 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2018-02-01+130,000→ 130,000 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2018-01-11$3.92/sh−637→ 5,303 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2018-01-11+1,950→ 5,940 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2018-01-11−1,950→ 5,850 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-09-18+12,000→ 12,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2017-09-18+50,000→ 50,000 total

Companies

Recent Filings

Address

2001 MARKET STREET SUITE 3915 UNIT #15

PHILADELPHIA, PA, 19103

View on SEC.gov